Targeted modulation of reactive oxygen species in the vascular endothelium

JOURNAL OF CONTROLLED RELEASE

卷:153

Article; Proceedings Paper

Muzykantov, Vladimir R.¹ 

[1] Univ Penn, Sch Med, Inst Environm Med, Dept Pharmacol, Philadelphia, PA 19104 USA

关键词: Endothelial cells;    Drug delivery;    Vascular immunotargeting;    Oxidative stress;    Antioxidant enzymes;   

DOI  :  10.1016/j.jconrel.2011.03.022

来源: Elsevier

【 摘 要 】

'Endothelial cells lining vascular luminal surface represent an important site of signaling and injurious effects of reactive oxygen species (ROS) produced by other cells and endothelium itself in ischemia, inflammation and other pathological conditions. Targeted delivery of ROS modulating enzymes conjugated with antibodies to endothelial surface molecules (vascular immunotargeting) provides site-specific interventions in the endothelial ROS, unattainable by other formulations including PEG-modified enzymes. Targeting of ROS generating enzymes (e.g., glucose oxidase) provides ROS- and site-specific models of endothelial oxidative stress, whereas targeting of antioxidant enzymes SOD and catalase offers site-specific quenching of superoxide anion and H202. These targeted antioxidant interventions help to clarify specific role of endothelial ROS in vascular and pulmonary pathologies and provide basis for design of targeted therapeutics for treatment of these pathologies. In particular, a ntibody/catalase conjugates alleviate acute lung ischemia/reperfusion injury, whereas antibody/SOD conjugates inhibit ROS-mediated vasoconstriction and inflammatory endothelial signaling. Encapsulation in proteaseresistant, ROS-permeable carriers targeted to endothelium prolongs protective effects of antioxidant enzymes, further diversifying the means for targeted modulation of endothelial ROS. (C) 2011 Elsevier B.V. All rights reserved.

【 授权许可】

Free